We investigated the prevalence of peripheral arterial disease (PAD). Primary Care Health Centers (n = 14) in Thessaly (central Greece) recruited 436 participants, mean age 71 (50-79) years. Peripheral arterial disease was considered present if the ankle–brachial index (ABI) was <0.9 or >1.4 in at least 1 leg. Asymptomatic PAD was defined as an abnormal ABI and no symptoms or history of limb revascularization. The prevalence of PAD was 13% (mostly asymptomatic, 11.7%). Only 5 (8.77%) of 57 patients with PAD were aware of their disease and only in these patients were the physicians aware of the presence of PAD. The risk factors associated with PAD were age, smoking, and the combination of diabetes mellitus and coronary artery disease. All symptomatic patients were on antiplatelet therapy but 33% did not take statins. For asymptomatic patients, 74.5% were not on antiplatelet therapy and 57% did not receive statins. In the primary health care setting, PAD is underdiagnosed and undertreated.
HirschATHiattWR. PAD awareness, risk, and treatment: new resources for survival—the USA PARTNERS program. Vasc Med. 2001;6(3 suppl):9–12.
2.
HirschATHaskalZJHertzerNR. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(11): e463–e654.
HirschATCriquiMHTreat-JacobsonD. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–1324.
5.
BhattDLStegPGOhmanEM. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295(2):180–189.
6.
SchrollMMunckO. Estimation of peripheral arteriosclerotic disease by ankle blood pressure measurements in a population study of 60-year-old men and women. J Chronic Dis. 1981;34(6):261–269.
7.
LengGCPapacostaOWhincupP. Femoral atherosclerosis in an older British population: prevalence and risk factors. Atherosclerosis. 2000;152(1):167–174.
8.
McDermottMMHahnEAGreenlandR. Atheroslerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med. 2002;17(12):895–904.
9.
McDermottMMMandapatALMoatesA. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med. 2003;163(18):2157–2162.
10.
Taylor-PiliaeREFairJMVaradyAN. Ankle brachial index screening in asymptomatic older adults. Am Heart J. 2011;161(5):979–985.
11.
CampbellNCMcNiffCSheranJBrittendenJLeeAJRitchieLD. Targeted screening for peripheral arterial disease in general practice: a pilot study in a high risk group. Br J Gen Pract. 2007;57(537):311–315.
12.
CacoubPCambouJPKownatorS. Prevalence of peripheral arterial disease in high-risk patients using ankle-brachial index in general practice: a cross-sectional study. Int J Clin Pract. 2009;63(1):63–70.
13.
RamosRQuesadaMSolanasP. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg. 2009;38(3):305–311.
14.
DoubeniCAYoodRAEmaniSGurwitzJH. Identifying unrecognized peripheral arterial disease among asymptomatic patients in the primary care setting. Angiology. 2006;57(2):171–180.
15.
Santo SignorelliSAnzaldiMFioreV. Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial comorbidity in Catania, Sicily, Italy. Angiology. 2010;61(6):524–529.
16.
KrogerKStangAKondratievaJ. Prevalence of peripheral arterial disease-results of the Heinz Nixdorf recall study. Eur J Epidemiol. 2006;21(4):279–285.
17.
HayozDBounameauxHCanovaCR. Swiss atherothrombosis survey: a field report on the occurrence of symptomatic and asymptomatic peripheral arterial disease. J Intern Med. 2005;258(3):238–243.
18.
DiehmCSchusterAAllenbergJR. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis. 2004;172(1):95–105.
19.
SelvinEErlingerTP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation. 2004;110(6):738–743.
20.
MeijerWTHoesAWRutgersDBotsMLHofmanAGrobbeeDE. Peripheral arterial disease in the elderly: the Rotterdam study. Arterioscler Thromb Vasc Biol. 1998;18(2):185–192.
21.
MurabitoJMEvansJCNietoKLarsonMGLevyDWilsonPW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143(6):961–965.
22.
StoffersHERinkensPEKesterADKaiserVKnottnerusJA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996;25(2):282–290.
23.
NewmanABSiscovickDSManolioTA. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation1993;88(3):837–845.
24.
HirschATHalversonSLTreat-JacobsonD. The Minnesota Regional Peripheral Arterial Disease Screening Program: toward a definition of community standards of care. Vasc Med. 2001;6(2):87–96.
25.
HooiJDStoffersHEKesterAD. Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. Scand J Prim Health Care. 1998;16(3):177–182.
26.
FowkesFGHousleyECawoodEHMacintyreCCRuckleyCVPrescottRJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20(2):384–392.
27.
SritaraPSritaraCWoodwardM. Prevalence and risk factors of peripheral arterial disease in a selected Thai population. Angiology. 2007;58(5):572–578.
28.
HankeyGJNormanPEEikelboomJW. Medical treatment of peripheral arterial disease. JAMA. 2006;295(5):547–553.
ParaskevasKIGiannoukasADMikhailidisDP. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected. Ann Vasc Surg. 2009;23(5):690–699.
31.
BianchiCMontalvoVOuHW. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Ann Vasc Surg. 2007;21(2):163–166.
32.
BrevettiGOlivaGGiuglianG. Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners. J Gen Intern Med. 2007;22(5):639–644.
